Development of DNA targeted platinum agents as potential anticancer drugs

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/251578

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

A number of clinically useful anticancer drugs damage DNA. As a result of this damage these drugs kill cancer cells. This project aims to develop new platinum-containing compounds which are specifically targeted to DNA. Through this strategy it is possible that new and more useful anticancer drugs could emerge.

Funded Activity Details

Start Date: 01-01-2003

End Date: 01-01-2005

Funding Scheme: NHMRC Project Grants

Funding Amount: $410,250.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical biochemistry and metabolomics not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Anticancer Drug Discovery | Cancer Chemotherapy | DNA Targeted Drugs | DNA Targeting | Drug Resistant Tumours | Novel Covalent Platinum Lesions | Platinum DNA Adduct Detection By DNA Sequencing

Related Links